Yurong LAI

Dr. Yurong LAI

drug metabolisms, Gilead Sciences (United States), Foster City, California, USA
+1
orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
MKMaria Karlgren
Maria Karlgren
AVAnna Vildhede
Anna Vildhede
UNUlf Norinder
Ulf Norinder
JWJacek R. Wisniewski
Jacek R. Wisniewski
EKEmi Kimoto
Emi Kimoto
PAPer Artursson
Per Artursson
The hepatic organic anion transporting polypeptides (OATPs) influence the pharmacokinetics of several drug classes and are involved in many clinical drug–drug interactions. Predicting potential interactions with OATPs is, therefore, of value. Here, we developed in vitro and in silico models for identification and prediction of specific and general inhibitors of OATP1B1, OATP1B3, and OATP2B1. The maximal transport activity (MTA) of each OATP in human liver was predicted from transport kinetics and protein quantification. We then used MTA to predict the effects of a subset of inhibitors on atorvastatin uptake in vivo. Using a data set of 225 drug-like compounds, 91 OATP inhibitors were identified. In silico models indicated that lipophilicity and polar surface area are key molecular features of OATP inhibition. MTA predictions identified OATP1B1 and OATP1B3 as major determinants of atorvastatin uptake in vivo. The relative contributions to overall hepatic uptake varied with isoform specificities of the inhibitors.

1 November 2011 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
LDLi Di
Li Di
CWCarrie Whitney‐Pickett
Carrie Whitney‐Pickett
JUJohn P. Umland
John P. Umland
HZHui Zhang
Hui Zhang
XZXun Zhang
Xun Zhang
MTMatthew D. Troutman
Matthew D. Troutman

10 April 2013 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
KBK L R Brouwer
K L R Brouwer
DKD Keppler
D Keppler
KHK A Hoffmaster
K A Hoffmaster
DBD A J Bow
D A J Bow
YCY Cheng
Y Cheng
RER Evers
R Evers

24 January 2024 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
AGAleksandra Galetin
Aleksandra Galetin
KBKim L. R. Brouwer
Kim L. R. Brouwer
DTDonald Tweedie
Donald Tweedie
KYKenta Yoshida
Kenta Yoshida
NSNoora Sjöstedt
Noora Sjöstedt
KGKathleen M. Giacomini
Kathleen M. Giacomini

11 September 2014 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
Marek DrozdzikMarek Drozdzik
Marek Drozdzik
CGChristian Gröer
Christian Gröer
JPJette Penski
Jette Penski
JŁJoanna Łapczuk-Romańska
Joanna Łapczuk-Romańska
MOMarek Ostrowski
Marek Ostrowski
SOStefan Oswald
Stefan Oswald

10 April 2013 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
XCX Chu
X Chu
AKand Ken Korzekwa
and Ken Korzekwa
RER Elsby
R Elsby
KFK Fenner
K Fenner
AGAleksandra Galetin
Aleksandra Galetin
KBK L R Brouwer
K L R Brouwer